Literature DB >> 10519333

Abnormal surfactant composition and activity in severe bronchiolitis.

R Skelton1, P Holland, M Darowski, P A Chetcuti, L W Morgan, J L Harwood.   

Abstract

A prospective study of infants under 1 y of age, ventilated for severe viral bronchiolitis, was carried out in four paediatric intensive care units in order to study surfactant activity and composition in this condition. Lung lavage fluid from 24 infants with bronchiolitis, 19 with bronchiolitis and sepsis or cardiac failure and 12 controls were analysed by the "click test" for surfactant activity and for phospholipids. Surfactant activity was present in all controls, but in only 2 of the 24 infants with bronchiolitis alone. The presence of phosphatidylglycerol correlated perfectly with the click test, suggesting that reduced activity is due to changes in surfactant lipid composition. In those with bronchiolitis plus coexisting disease, surfactant activity and phosphatidylglycerol were absent in only half. Surfactant activity and phosphatidylglycerol re-appeared by extubation. Severe viral bronchiolitis is associated with an absence of surfactant activity and PG, which resolves by clinical recovery. Infants with coexisting conditions are not always surfactant deficient. Surfactant administration is likely to be beneficial, but requires a selective approach.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10519333     DOI: 10.1080/08035259950168414

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  10 in total

Review 1.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

Review 2.  Surfactant for pediatric acute lung injury.

Authors:  Douglas F Willson; Patricia R Chess; Robert H Notter
Journal:  Pediatr Clin North Am       Date:  2008-06       Impact factor: 3.278

Review 3.  The Human Immune Response to Respiratory Syncytial Virus Infection.

Authors:  Clark D Russell; Stefan A Unger; Marc Walton; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

Review 4.  Surfactant therapy for bronchiolitis in critically ill infants.

Authors:  Kana R Jat; Deepak Chawla
Journal:  Cochrane Database Syst Rev       Date:  2015-08-24

Review 5.  Bench-to-bedside review: Paediatric viral lower respiratory tract disease necessitating mechanical ventilation--should we use exogenous surfactant?

Authors:  Martin C J Kneyber; Frans B Plötz; Jan L L Kimpen
Journal:  Crit Care       Date:  2005-10-05       Impact factor: 9.097

6.  Association of SNP-SNP Interactions of Surfactant Protein Genes with Pediatric Acute Respiratory Failure.

Authors:  Chintan K Gandhi; Chixiang Chen; Rongling Wu; Lili Yang; Nithyananda Thorenoor; Neal J Thomas; Susan L DiAngelo; Debbie Spear; Garrett Keim; Nadir Yehya; Joanna Floros
Journal:  J Clin Med       Date:  2020-04-20       Impact factor: 4.241

7.  Efficacy and safety of exogenous surfactant therapy in patients under 12 months of age invasively ventilated for severe bronchiolitis (SURFABRON): protocol for a multicentre, randomised, double-blind, controlled, non-profit trial.

Authors:  Paolo Biban; Giorgio Conti; Andrea Michele Wolfler; Silvia Carlassara; Eloisa Gitto; Immacolata Rulli; Andrea Moscatelli; Camilla Micalizzi; Fabio Savron; Raffaella Sagredini; Giulia Genoni; Marco Binotti; Fabio Caramelli; Monica Fae; Andrea Pettenazzo; Valentina Stritoni; Luigia D'Amato; Geremia Zito Marinosci; Edoardo Calderini; Stefano Scalia Catenacci; Alberto Berardi; Francesco Torcetta; Ezio Bonanomi; Daniele Bonacina; Giorgio Ivani; Pierantonio Santuz
Journal:  BMJ Open       Date:  2020-10-19       Impact factor: 2.692

8.  Budget impact analysis of surfactant therapy for bronchiolitis in critically ill infants: the Colombian National Health System perspective.

Authors:  Jefferson Antonio Buendía; Diana Guerrero Patiño
Journal:  BMC Health Serv Res       Date:  2021-04-13       Impact factor: 2.655

Review 9.  Surfactant therapy for acute respiratory failure in children: a systematic review and meta-analysis.

Authors:  Mark Duffett; Karen Choong; Vivian Ng; Adrienne Randolph; Deborah J Cook
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 10.  Rational use of mucoactive medications to treat pediatric airway disease.

Authors:  R S N Linssen; J Ma; R A Bem; B K Rubin
Journal:  Paediatr Respir Rev       Date:  2020-06-16       Impact factor: 2.726

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.